Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Aflibercept in macular oedema: Added benefit not proven

Science Daily - 7 Jan 2014 20:59
Due to a lack of suitable data, it is not proven that visual impairment in macular oedema can be treated more effectively with aflibercept than with the appropriate comparator therapy.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard